NKE
NIKE, Inc.
NKE has the edge over ZUMZ overall, supported by stronger valuation and lower modeled downside.
ZUMZ
Zumiez Inc.
ZUMZ offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
ZUMZ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ZUMZ's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over ZUMZ in the historical PE scenario, which offers more potential upside but is not a forecast.
ZUMZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.1x | $5.19 | -63% |
| Fair | 14x | $8.64 | -39% |
| Current | 22x | $14.09 | — |
| Expensive | 25x | $16.27 | +15% |
| Forward | 34x | $14.09 | — |
Historical ranges are pointers, not guarantees.
ZUMZ's PE is in its expensive range at 22x. On analysts' estimates for next year's earnings, today's price would be 34x.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
ZUMZ Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect ZUMZ's earnings to grow, with its revenue and profitability holding steady. However, they disagree widely on these estimates.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
ZUMZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.42 | -35% |
| Q3 2026 | $0.64 | +$0.68 |
| Q2 2026 | $0.75 | +$0.77 |
| Q1 2026 | $0.78 | +$0.87 |
| Q4 2025 | $0.45 | +$3.02 |
| Q3 2025 | -$0.04 | +$2.71 |
| Q2 2025 | -$0.02 | +$3.13 |
| Q1 2025 | -$0.09 | +$3.16 |
| Q4 2024 | -$2.57 | -$1.63 |
ZUMZ has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over ZUMZ on profitability, with a higher operating margin.
ZUMZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $209M | -2.5% |
| Q2 2026 | $193.3M | +4.9% |
| Q1 2026 | $291.3M | +4.4% |
| Q4 2025 | $239.1M | +7.5% |
| Q3 2025 | $214.3M | +1.9% |
| Q2 2025 | $184.3M | +3.9% |
| Q1 2025 | $279.2M | -0.9% |
| Q4 2024 | $222.5M | +2.8% |
ZUMZ has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.6% | -0.7 points |
| Q2 2026 | -7.9% | +2.9 points |
| Q1 2026 | 8.6% | +1.4 points |
| Q4 2025 | 4.9% | +3.9 points |
| Q3 2025 | 0.1% | +0.2 points |
| Q2 2025 | -11% | +0.6 points |
| Q1 2025 | 7.2% | +19 points |
| Q4 2024 | 1.1% | +1.1 points |
ZUMZ's operating margin was −0.6% last quarter, down 0.7 points from the same quarter a year ago.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
ZUMZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.4M | -125% |
| Q2 2026 | -$29.8M | -$5.5M |
| Q1 2026 | $54.1M | +8.9% |
| Q4 2025 | $3.1M | +$25.4M |
| Q3 2025 | $9.5M | +$10.1M |
| Q2 2025 | -$24.3M | -$3.2M |
| Q1 2025 | $49.7M | +48% |
| Q4 2024 | -$22.3M | -$19.3M |
ZUMZ has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
ZUMZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.1% | -497K shares |
| 1 year | -5.9% | -990K shares |
| 3 years | -19% | -3.6M shares |
| 5 years | -39% | -9.9M shares |
| Available history | -39% | -9.9M shares |
ZUMZ has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $23M |
| Q2 2026 | $6M |
| Q1 2026 | — |
| Q4 2025 | $5.6M |
| Q3 2025 | $7.5M |
| Q2 2025 | $25.2M |
| Q1 2025 | — |
| Q4 2024 | $5.6M |
ZUMZ spent $35M buying back its own shares over the past year, down 9.8% from the year before.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
ZUMZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -3.4x | Net Cash |
| Q4 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -4.7x | Net Cash |
| Q4 2023 | -9.4x | Net Cash |
| Q3 2023 | -3.7x | Net Cash |
ZUMZ has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
ZUMZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.8 | Neutral |
| Stochastic | 18.2 | Oversold |
ZUMZ's weekly RSI is 37 (neutral) and its Stochastic is 18 (oversold).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over ZUMZ on valuation relative to its sector.
ZUMZ PE vs Consumer Cyclical Sector
| Metric | ZUMZ | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 22% above |
| PE % | 76 | 47 | 29 pts above |
ZUMZ is trading at 22x earnings, a 22% premium to the Consumer Cyclical sector's median of 18x.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
ZUMZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.1 | 0.2% above |
| 20 week MA | $16.3 | 14% below |
| 50 week MA | $20.9 | 33% below |
| 100 week MA | $18.6 | 24% below |
| 200 week MA | $19.0 | 26% below |
ZUMZ has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 26% below its 200-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has the edge over ZUMZ on returns for 2026, with the stronger performance.
ZUMZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.7 | $36.0 | +10% |
| 2021 | $36.0 | $45.9 | +27% |
| 2022 | $45.9 | $21.0 | -54% |
| 2023 | $21.0 | $20.3 | -3.2% |
| 2024 | $20.3 | $19.5 | -4.3% |
| 2025 | $19.5 | $27.2 | +40% |
| 2026 YTD | $27.2 | $14.1 | -48% |
ZUMZ has finished lower in three of the last six years. It's down 48% so far in 2026.